awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33402885-1A1B1325-E1CA-4D9F-BE1A-370F1B37A2AB
Q33402885-1A1B1325-E1CA-4D9F-BE1A-370F1B37A2AB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33402885-1A1B1325-E1CA-4D9F-BE1A-370F1B37A2AB
Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidation.
P2860
Q33402885-1A1B1325-E1CA-4D9F-BE1A-370F1B37A2AB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33402885-1A1B1325-E1CA-4D9F-BE1A-370F1B37A2AB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
112801a9f0c6441a0e197b7f382689d5de928a13
P2860
Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma